|
JPS5117165B1
(enExample)
|
1973-12-27 |
1976-05-31 |
|
|
|
US4318846A
(en)
|
1979-09-07 |
1982-03-09 |
Syva Company |
Novel ether substituted fluorescein polyamino acid compounds as fluorescers and quenchers
|
|
US5516931A
(en)
|
1982-02-01 |
1996-05-14 |
Northeastern University |
Release tag compounds producing ketone signal groups
|
|
US4650750A
(en)
|
1982-02-01 |
1987-03-17 |
Giese Roger W |
Method of chemical analysis employing molecular release tag compounds
|
|
US4709016A
(en)
|
1982-02-01 |
1987-11-24 |
Northeastern University |
Molecular analytical release tags and their use in chemical analysis
|
|
US4968603A
(en)
|
1986-12-31 |
1990-11-06 |
The Regents Of The University Of California |
Determination of status in neoplastic disease
|
|
WO1989006692A1
(en)
|
1988-01-12 |
1989-07-27 |
Genentech, Inc. |
Method of treating tumor cells by inhibiting growth factor receptor function
|
|
JP2681061B2
(ja)
|
1988-06-08 |
1997-11-19 |
ロンドン・ダイアグノスティック・インコーポレーテッド |
検出可能なシグナルのセンシタイザー誘導発生を利用したアッセイ
|
|
US5183884A
(en)
|
1989-12-01 |
1993-02-02 |
United States Of America |
Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor
|
|
ES2094795T3
(es)
|
1990-11-02 |
1997-02-01 |
Ici Plc |
Ftalocianinas polisustituidas.
|
|
US5340716A
(en)
|
1991-06-20 |
1994-08-23 |
Snytex (U.S.A.) Inc. |
Assay method utilizing photoactivated chemiluminescent label
|
|
US5578498A
(en)
|
1991-05-22 |
1996-11-26 |
Behringwerke Ag |
Metal chelate containing compositions for use in chemiluminescent assays
|
|
US6251581B1
(en)
|
1991-05-22 |
2001-06-26 |
Dade Behring Marburg Gmbh |
Assay method utilizing induced luminescence
|
|
US5565552A
(en)
|
1992-01-21 |
1996-10-15 |
Pharmacyclics, Inc. |
Method of expanded porphyrin-oligonucleotide conjugate synthesis
|
|
US5622929A
(en)
|
1992-01-23 |
1997-04-22 |
Bristol-Myers Squibb Company |
Thioether conjugates
|
|
DE69333807T2
(de)
|
1992-02-06 |
2006-02-02 |
Chiron Corp., Emeryville |
Marker für krebs und biosynthetisches bindeprotein dafür
|
|
ES2113547T3
(es)
|
1992-07-31 |
1998-05-01 |
Behringwerke Ag |
Matrices quimioluminiscentes fotoactivables.
|
|
US5565324A
(en)
|
1992-10-01 |
1996-10-15 |
The Trustees Of Columbia University In The City Of New York |
Complex combinatorial chemical libraries encoded with tags
|
|
JPH09512705A
(ja)
|
1994-03-29 |
1997-12-22 |
セルテック セラピューティクス リミテッド |
Ｅ−セレクチンに対する抗体
|
|
US5986076A
(en)
|
1994-05-11 |
1999-11-16 |
Trustees Of Boston University |
Photocleavable agents and conjugates for the detection and isolation of biomolecules
|
|
US5968511A
(en)
|
1996-03-27 |
1999-10-19 |
Genentech, Inc. |
ErbB3 antibodies
|
|
SE9601676D0
(sv)
|
1996-04-30 |
1996-04-30 |
Ulf Landegren |
Improved probing of specific mucleic acids
|
|
US5945526A
(en)
|
1996-05-03 |
1999-08-31 |
Perkin-Elmer Corporation |
Energy transfer dyes with enhanced fluorescence
|
|
US5763602A
(en)
|
1996-10-01 |
1998-06-09 |
Li; Ying-Syi |
Methods of syntheses of phthalocyanine compounds
|
|
US7371376B1
(en)
|
1996-10-18 |
2008-05-13 |
Genentech, Inc. |
Anti-ErbB2 antibodies
|
|
ZA9811162B
(en)
|
1997-12-12 |
2000-06-07 |
Genentech Inc |
Treatment with anti-ERBB2 antibodies.
|
|
US6175752B1
(en)
|
1998-04-30 |
2001-01-16 |
Therasense, Inc. |
Analyte monitoring device and methods of use
|
|
US6541214B1
(en)
|
1998-11-13 |
2003-04-01 |
Oregon Heath Science University |
N-terminally truncated HER-2/neu protein as a cancer prognostic indicator
|
|
US6001673A
(en)
|
1999-02-11 |
1999-12-14 |
Ericsson Inc. |
Methods for packaging integrated circuit devices including cavities adjacent active regions
|
|
US6682887B1
(en)
|
1999-04-30 |
2004-01-27 |
Aclara Biosciences, Inc. |
Detection using degradation of a tagged sequence
|
|
US6322980B1
(en)
|
1999-04-30 |
2001-11-27 |
Aclara Biosciences, Inc. |
Single nucleotide detection using degradation of a fluorescent sequence
|
|
US6514700B1
(en)
|
1999-04-30 |
2003-02-04 |
Aclara Biosciences, Inc. |
Nucleic acid detection using degradation of a tagged sequence
|
|
US20040248150A1
(en)
|
1999-04-02 |
2004-12-09 |
Sharat Singh |
Methods employing oligonucleotide-binding e-tag probes
|
|
US6627400B1
(en)
|
1999-04-30 |
2003-09-30 |
Aclara Biosciences, Inc. |
Multiplexed measurement of membrane protein populations
|
|
US6649351B2
(en)
|
1999-04-30 |
2003-11-18 |
Aclara Biosciences, Inc. |
Methods for detecting a plurality of analytes by mass spectrometry
|
|
US7037654B2
(en)
|
1999-04-30 |
2006-05-02 |
Aclara Biosciences, Inc. |
Methods and compositions for enhancing detection in determinations employing cleavable electrophoretic tag reagents
|
|
US20030092012A1
(en)
|
2001-11-09 |
2003-05-15 |
Ahmed Chenna |
Methods for detecting a plurality of analytes by chromatography
|
|
US7001725B2
(en)
|
1999-04-30 |
2006-02-21 |
Aclara Biosciences, Inc. |
Kits employing generalized target-binding e-tag probes
|
|
US6673550B2
(en)
|
1999-04-30 |
2004-01-06 |
Aclara Biosciences, Inc. |
Electrophoretic tag reagents comprising fluorescent compounds
|
|
US20030235832A1
(en)
|
2000-06-21 |
2003-12-25 |
Ahmed Chenna |
Multiplexed analysis by chromatographic separation of molecular tags
|
|
DK1187632T3
(da)
|
1999-05-14 |
2009-04-06 |
Genentech Inc |
Behandling med anti-ErbB2-antistoffer
|
|
US6627196B1
(en)
|
1999-08-27 |
2003-09-30 |
Genentech, Inc. |
Dosages for treatment with anti-ErbB2 antibodies
|
|
AU2951801A
(en)
*
|
2000-01-12 |
2001-07-24 |
Ventana Medical Systems, Inc. |
Method for quantitating a protein by image analysis
|
|
US7306904B2
(en)
|
2000-02-18 |
2007-12-11 |
Olink Ab |
Methods and kits for proximity probing
|
|
MY133839A
(en)
|
2000-03-14 |
2007-11-30 |
Shell Int Research |
Process for the carbonylation of pentenenitrile
|
|
GB0007911D0
(en)
|
2000-03-30 |
2000-05-17 |
Novartis Ag |
Organic compounds
|
|
US7537938B2
(en)
|
2000-04-28 |
2009-05-26 |
Monogram Biosciences, Inc. |
Biomarker detection in circulating cells
|
|
US7160735B2
(en)
|
2000-04-28 |
2007-01-09 |
Monogram Biosciences, Inc. |
Tagged microparticle compositions and methods
|
|
US20040067498A1
(en)
|
2000-04-28 |
2004-04-08 |
Ahmed Chenna |
Detection of nucleic acid sequences by cleavage and separation of tag-containing structures
|
|
US20030170734A1
(en)
|
2000-04-28 |
2003-09-11 |
Stephen Williams |
Multiplexed assays using electrophoretically separated molecular tags
|
|
US7771929B2
(en)
|
2000-04-28 |
2010-08-10 |
Monogram Biosciences, Inc. |
Tag library compounds, compositions, kits and methods of use
|
|
US20030207300A1
(en)
|
2000-04-28 |
2003-11-06 |
Matray Tracy J. |
Multiplex analytical platform using molecular tags
|
|
WO2001084157A2
(en)
|
2000-05-04 |
2001-11-08 |
Dade Behring Marburg Gmbh |
Compositions for detection of multiple analytes
|
|
US6547654B2
(en)
|
2000-07-22 |
2003-04-15 |
Americo Del Raso |
Automatic abrasive sleeve tightening means and quick release system for an oscillating spindle sander
|
|
WO2002012547A1
(en)
|
2000-08-08 |
2002-02-14 |
Aclara Biosciences, Inc. |
Multiplexed enzymatic assays
|
|
WO2002017437A1
(en)
|
2000-08-19 |
2002-02-28 |
Kim Sung Cheol |
Communication line separator
|
|
EP1236740B1
(de)
|
2001-02-28 |
2012-07-18 |
Bio Life Science Forschungs- und Entwicklungsges.m.b.H. |
Vakzine gegen Krebserkrankungen, die mit dem HER-2/neu Onkogen assoziiert sind
|
|
US7183388B2
(en)
|
2001-03-30 |
2007-02-27 |
The Regents Of The University Of California |
Anti-MUC-1 single chain antibodies for tumor targeting
|
|
JP2005505749A
(ja)
|
2001-05-21 |
2005-02-24 |
アクララ バイオサイエンシーズ， インコーポレイテッド |
タンパク質を分析するための方法および組成物
|
|
AU2002305658A1
(en)
|
2001-05-21 |
2002-12-03 |
Aclara Biosciences, Inc. |
Analyzing phosphorylated proteins
|
|
US7358052B2
(en)
|
2001-05-26 |
2008-04-15 |
Monogram Biosciences, Inc. |
Catalytic amplification of multiplexed assay signals
|
|
AU2002316577A1
(en)
|
2001-07-09 |
2003-01-29 |
Aclara Biosciences, Inc. |
Cell-screening assay and composition
|
|
US7446185B2
(en)
|
2001-07-18 |
2008-11-04 |
The Regents Of The University Of California |
Her2/neu target antigen and use of same to stimulate an immune response
|
|
US20040241688A1
(en)
|
2001-07-19 |
2004-12-02 |
Cuneyt Bukusoglu |
Human tissue specific drug screening procedure
|
|
GB2378245A
(en)
|
2001-08-03 |
2003-02-05 |
Mats Nilsson |
Nucleic acid amplification method
|
|
CA2456732C
(en)
|
2001-08-07 |
2012-10-30 |
Galephar M/F |
Oral pharmaceutical composition containing a combination of ppar.alpha. and a hmg-coa reductase inhibitor
|
|
EP1283053A1
(en)
|
2001-08-09 |
2003-02-12 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Inhibitors of HER3 activity
|
|
EP1434535A1
(en)
|
2001-10-12 |
2004-07-07 |
Gyne Ideas Limited |
Biomaterial comprising microfeatures
|
|
WO2003033741A1
(en)
|
2001-10-16 |
2003-04-24 |
Aclara Biosciences, Inc. |
Universal e-tag primer and probe compositions and methods
|
|
US7045311B2
(en)
|
2001-10-25 |
2006-05-16 |
Monogram Biosciences, Inc. |
Whole cell assay systems for cell surface proteases
|
|
JP2005509859A
(ja)
|
2001-11-09 |
2005-04-14 |
アクララ バイオサイエンシーズ， インコーポレイテッド |
タグ標識された微粒子組成物および方法
|
|
CA2465588A1
(en)
|
2001-11-09 |
2003-05-22 |
Aclara Biosciences, Inc. |
Detection of nucleic acid sequences by cleavage and separation of tag-containing structures
|
|
WO2003042658A2
(en)
|
2001-11-09 |
2003-05-22 |
Aclara Biosciences, Inc. |
Methods and compositions for enhancing detection in determinations employing cleavable electrophoretic tag reagents
|
|
US7341362B2
(en)
|
2001-12-18 |
2008-03-11 |
Monogram Biosciences, Inc. |
Photoactivation device and method
|
|
US7135174B2
(en)
*
|
2002-01-07 |
2006-11-14 |
Amgen Fremont, Inc. |
Antibodies directed to PDGFD and uses thereof
|
|
JP4488746B2
(ja)
*
|
2002-02-26 |
2010-06-23 |
シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ |
抗−ヒトテネイシンモノクローナル抗体
|
|
JP2006509183A
(ja)
|
2002-03-05 |
2006-03-16 |
アクララ バイオサイエンシーズ， インコーポレイテッド |
膜結合増感剤を用いる多重分析
|
|
DK3115470T3
(en)
|
2002-03-13 |
2018-11-05 |
Genomic Health Inc |
Gene Expression Profiling in Tumor Tissue Biopsies
|
|
JP2005521885A
(ja)
|
2002-04-02 |
2005-07-21 |
アクララ バイオサイエンシーズ， インコーポレイテッド |
電気泳動的に分離される分子タグを使用する多重化アッセイ
|
|
US7332580B2
(en)
|
2002-04-05 |
2008-02-19 |
The Regents Of The University Of California |
Bispecific single chain Fv antibody molecules and methods of use thereof
|
|
US20040248151A1
(en)
|
2002-04-05 |
2004-12-09 |
Ventana Medical Systems, Inc. |
Method for predicting the response to HER2-directed therapy
|
|
US20040229294A1
(en)
|
2002-05-21 |
2004-11-18 |
Po-Ying Chan-Hui |
ErbB surface receptor complexes as biomarkers
|
|
US20040229293A1
(en)
|
2002-05-21 |
2004-11-18 |
Po-Ying Chan-Hui |
Surface receptor complexes as biomarkers
|
|
US7105308B2
(en)
|
2002-07-25 |
2006-09-12 |
Monogram Biosciences, Inc. |
Detecting receptor oligomerization
|
|
US20040229380A1
(en)
|
2002-05-21 |
2004-11-18 |
Po-Ying Chan-Hui |
ErbB heterodimers as biomarkers
|
|
US7402397B2
(en)
|
2002-05-21 |
2008-07-22 |
Monogram Biosciences, Inc. |
Detecting and profiling molecular complexes
|
|
US20090111127A1
(en)
|
2002-05-21 |
2009-04-30 |
Monogram Biosciences Inc. |
Surface Receptor Complexes as Biomarkers
|
|
US20040229299A1
(en)
|
2002-05-21 |
2004-11-18 |
Badal M. Youssouf |
Intracellular complexes as biomarkers
|
|
US20040175765A1
(en)
|
2002-07-05 |
2004-09-09 |
Sharat Singh |
Cell-screening assay and composition
|
|
EP2263691B1
(en)
*
|
2002-07-15 |
2012-08-29 |
F.Hoffmann-La Roche Ag |
Treatment of cancer with the recombinant humanized monoclonal anti-erbb2 antibody 2C4 (rhuMAb 2C4)
|
|
CA2493671A1
(en)
|
2002-07-26 |
2004-02-05 |
Aclara Biosciences, Inc. |
Lipophilic electrophoretic probes
|
|
US20040091850A1
(en)
|
2002-11-08 |
2004-05-13 |
Travis Boone |
Single cell analysis of membrane molecules
|
|
WO2004061131A1
(en)
|
2002-12-18 |
2004-07-22 |
Aclara Biosciences, Inc. |
Multiplexed immunohistochemical assays using molecular tags
|
|
JP2007504482A
(ja)
|
2003-01-17 |
2007-03-01 |
アクララ バイオサイエンシーズ， インコーポレイテッド |
タグ付加分子ライブラリーを使用した受容体の脱オーファン化
|
|
WO2004087887A2
(en)
|
2003-04-01 |
2004-10-14 |
Monogram Biosciences, Inc. |
Intracellular complexes as biomarkers
|
|
US7402398B2
(en)
|
2003-07-17 |
2008-07-22 |
Monogram Biosciences, Inc. |
Measuring receptor homodimerization
|
|
US20100291594A1
(en)
|
2003-07-17 |
2010-11-18 |
Laboratory Corporation Of America Holdings |
ErbB Surface Receptor Complexes as Biomarkers
|
|
WO2005011607A2
(en)
*
|
2003-08-01 |
2005-02-10 |
Smithkline Beecham Corporation |
Treatment of cancers expressing p95 erbb2
|
|
CA2535510C
(en)
|
2003-08-11 |
2013-10-15 |
Monogram Biosciences, Inc. |
Detecting and profiling molecular complexes
|
|
EP1664716A4
(en)
|
2003-08-15 |
2008-08-13 |
Smithkline Beecham Corp |
CANCER BIOMARKERS
|
|
US20050106571A1
(en)
|
2003-10-02 |
2005-05-19 |
The Regents Of The University Of California |
Mammalian T1R3 sweet taste receptors
|
|
US7402399B2
(en)
|
2003-10-14 |
2008-07-22 |
Monogram Biosciences, Inc. |
Receptor tyrosine kinase signaling pathway analysis for diagnosis and therapy
|
|
CA2543830A1
(en)
|
2003-10-27 |
2005-05-19 |
Monogram Biosciences, Inc. |
Detecting human anti-therapeutic antibodies
|
|
PL1674111T3
(pl)
|
2004-07-09 |
2011-04-29 |
Chugai Pharmaceutical Co Ltd |
Przeciwciała anty-glipikan 3
|
|
WO2006044748A2
(en)
|
2004-10-15 |
2006-04-27 |
Monogram Biosciences, Inc. |
RESPONSE PREDICTORS FOR ErbB PATHWAY-SPECIFIC DRUGS
|
|
AU2005333156B2
(en)
|
2004-11-03 |
2011-05-26 |
Iris Molecular Diagnostics, Inc. |
Homogeneous analyte detection
|
|
US7939267B2
(en)
|
2004-11-04 |
2011-05-10 |
Laboratory Corporation Of America Holdings |
Detection of activation of endothelial cells as surrogate marker for angiogenesis
|
|
US7862995B2
(en)
*
|
2004-12-10 |
2011-01-04 |
Targeted Molecular Diagnostics |
Methods and materials for predicting responsiveness to treatment with dual tyrosine kinase inhibitor
|
|
CA2601700A1
(en)
*
|
2004-12-21 |
2006-06-29 |
Cell Signaling Technology, Inc. |
Protein phosphorylation in egfr-signaling pathways
|
|
WO2006084018A2
(en)
|
2005-02-02 |
2006-08-10 |
Monogram Biosciences, Inc. |
Methods for determining responsiveness to cancer therapy
|
|
JP2008530123A
(ja)
*
|
2005-02-09 |
2008-08-07 |
ジェネンテック・インコーポレーテッド |
マトリックスメタロプロテアーゼアンタゴニストを用いたｈｅｒ２のシェディングの阻害
|
|
US20060212956A1
(en)
|
2005-03-14 |
2006-09-21 |
Genentech, Inc. |
Animal model of ligand activated HER2 expressing tumors
|
|
JP2006316040A
(ja)
|
2005-05-13 |
2006-11-24 |
Genentech Inc |
Ｈｅｒｃｅｐｔｉｎ（登録商標）補助療法
|
|
WO2006133460A2
(en)
*
|
2005-06-09 |
2006-12-14 |
Yale University |
Methods for diagnosing and treating breast cancer based on a her/er ratio
|
|
US7700299B2
(en)
|
2005-08-12 |
2010-04-20 |
Hoffmann-La Roche Inc. |
Method for predicting the response to a treatment
|
|
CN1928563B
(zh)
|
2005-09-09 |
2010-04-28 |
上海张江生物技术有限公司 |
乳腺癌的免疫组化诊断试剂盒和测试片
|
|
WO2007041502A2
(en)
*
|
2005-09-30 |
2007-04-12 |
Monogram Biosciences |
Methods for determining responsiveness to cancer therapy
|
|
EP2049568A2
(en)
|
2006-04-07 |
2009-04-22 |
Københavns Universitet |
Erbb receptor-derived peptide fragments
|
|
EP1997832A1
(en)
*
|
2007-05-29 |
2008-12-03 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against Claudin-18 for treatment of cancer
|
|
JP5117165B2
(ja)
|
2007-11-09 |
2013-01-09 |
花王株式会社 |
水中油型乳化組成物の製造方法
|
|
CA2706763C
(en)
|
2007-11-27 |
2013-07-30 |
Laboratory Corporation Of America Holdings |
Enhanced method for detecting and/or quantifying an analyte in a sample
|
|
CN101230390A
(zh)
|
2007-12-07 |
2008-07-30 |
湖北大学 |
一种用于妇科恶性肿瘤早期筛选的基因芯片及其检测方法
|
|
CA2711843C
(en)
|
2007-12-20 |
2018-11-13 |
Laboratory Corporation Of America Holdings |
Her-2 diagnostic methods
|
|
ES2342646B1
(es)
|
2008-06-02 |
2011-04-26 |
Institut De Recerca Hospital Universitari Vall Hebron |
Metodo de diagnostico de canceres que expresan el receptor her-2 o sus variantes truncadas.
|
|
WO2010037395A2
(en)
|
2008-10-01 |
2010-04-08 |
Dako Denmark A/S |
Mhc multimers in cancer vaccines and immune monitoring
|
|
US8470542B2
(en)
|
2008-12-01 |
2013-06-25 |
Laboratory Corporation Of America Holdings |
Methods and assays for measuring p95 and/or p95 complexes in a sample and antibodies specific for p95
|
|
SG172983A1
(en)
|
2009-01-15 |
2011-08-29 |
Lab Corp America Holdings |
Methods of determining patient response by measurement of her-3
|
|
BRPI1007048A2
(pt)
|
2009-01-15 |
2016-02-10 |
Lab Corp America Holdings |
método e kit para correlacionar os níveis relativos da quantidade de pelo menos um de her-2 ou homodímeros de her-2 em uma amostra biológica de um indivíduo, e , método para prognosticar se um indivíduo com câncer e que é tratado com um agente que atua em her-2 é provável ter um evento significante.
|